SS.docx

SOURCES SOUGHT

CATSmart Continuous Autotransfusion This is a Sources Sought (SS) Notice only; it is not a Solicitation (i.e., Request for Proposal, Request for Quotation, or Invitation for Bids). This SS is part of the Government’s market research effort to determine the scope of industry capabilities and interest and will be treated as information only. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. Responses to this SS are strictly voluntary, and the Government will not pay respondents for information provided in response to this SS. Responses to this SS will not be returned, and respondents will not be notified of the result of the review. Although, responses to the questions posed by the Government would be most beneficial to this market research effort.

The purpose of this SS is to conduct Market Research to determine an acquisition strategy, to include determining if there are a sufficient number of Small Businesses capable of performing the requirements to warrant a set-aside, for the procurement of a Fresenius CATSmart Continuous Autotransfusion System at the Louis Stokes Cleveland VA Medical Center (CLE VAMC), 10701 East Blvd., Cleveland, OH 44106.

The Fresenius CATSmart Continuous Autotransfusion System is a continuous autotransfusion medical device designed to collect, wash, and reinfuse a patient’s own blood during surgery, reducing the need for allogeneic blood. The system utilizes continuous flow technology, allowing for simultaneous blood separation and washing to provide high-quality packed red cells (PRC) rapidly. The CATSmart system is used during surgical procedures requiring intraoperative blood recovery and is currently utilized by multiple services, including Anesthesia, Perfusion (Cardiac), and Vascular. The Government requires four (4) CATSmart Continuous Autotransfusion Systems, along with four (4) CATSmart Auto-Start Reservoir Holders. The current units are significantly past End of Life and are no longer serviceable, requiring replacement to support continued surgical operations. Potential sources must demonstrate the capability to provide the required equipment.

Potential sources should submit:

• Point of Contact with email address and phone number;

• Business name and address;

• Applicable business socio-economic category;

• GSA, NAC, TAC, or SAC contract number if applicable;

• Capability statement and/or brochures of the equipment to allow for assessment of meeting the requirements stated above;

• SAM UEI number;

• Delivery days After Receipt of Order (ARO);

• What country the product is made in; and

• Whether or not your company is the OEM or a distributor. If a distributor, indicate who the OEM is and provide an authorized distributor letter.

Proprietary/Competition Sensitive information (appropriately marked) will be protected from disclosure to the greatest extent practical, however it is preferred that respondents do not provide proprietary or otherwise restricted responses unless they are indicating proprietary technical characteristics.

Vendors are hereby notified that if a competitive solicitation is issued on the Beta SAM website https://sam.gov at a later date, all interested parties must respond to that Solicitation announcement separately from any response to this SS announcement. This SS does not restrict the Government's acquisition approach on a future Solicitation.

No faxes, courier-delivered, or telephone inquiries/submissions will be accepted. Responses should be submitted to Rachelle J. Hamer, Contracting Officer, at rachelle.hamer@va.gov, by Wednesday, September 9, 2026, by 8AM ET. Enter “RFI 36C25026Q0958 | CATSmart Continuous Autotransfusion in the email subject line.